Intrinsiqq
Nykode Therapeutics ASA logo

Nykode Therapeutics ASA Dividend Analysis

NYKD.XOSL

Compare
Dividend0
No current dividend

This company does not have a meaningful dividend profile under this framework.

Based on TTM and annual data · Not a buy/sell signal

Score Breakdown

0

Safety

40% of composite

Earnings Payout0
N/ANot reported
FCF Payout0
N/ANo data
0

Growth

35% of composite

Dividend Streak0
0YNo sustained streak
Growth Rate0
N/ANo data
0

Income

25% of composite

Cash Yield (TTM)0
N/ANo data

Composite = Safety (0) × 0.40 + Growth (0) × 0.35 + Income (0) × 0.25 = 0

Dividend Safety

Earnings Payout

Not reported

FCF Payout

–

FCF Coverage

–

Dividend Growth

Per Share (TTM)

$0.00

Growth Streak

–

CAGR

–

Dividend history

Dividend per share by fiscal year
Fiscal yearPer shareChange
2024$0.10

Each payment counts toward the fiscal year it is paid for, so a final dividend paid in spring belongs to the year before. Figures are adjusted for stock splits, so a fall is a cut.

Computed from company filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.

Yield History

Does Nykode Therapeutics ASA (NYKD.XOSL) pay a dividend?

Frequently asked

Does Nykode Therapeutics ASA (NYKD.XOSL) pay a dividend?+

No. Nykode Therapeutics ASA (NYKD.XOSL) does not currently pay a dividend. The last payment in our data was in 2024, and nothing has been paid since.

How does Nykode Therapeutics ASA return cash to shareholders?+

It largely does not. Nykode Therapeutics ASA pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.

Could Nykode Therapeutics ASA afford to pay a dividend?+

Not currently. Nykode Therapeutics ASA's free cash flow is negative at -$27 million, meaning the business consumed cash over the period rather than generating it. A company funding a dividend from cash it is not producing would be paying shareholders out of its balance sheet or borrowings, which is not sustainable.

Which healthcare companies do pay dividends?+

Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Nykode Therapeutics ASA.

Peers

Biotechnology · Pick stocks to compare with NYKD.XOSL

CompareIntrinsic value
SOFTX.XOSLSoftOx Solutions AS
€0.01+0.00%10
HBC.XOSLHofseth BioCare ASA
€0.09+0.00%30
NAVA.XOSLNavamedic ASA
€0.95-3.85%29
ONCIN.XOSLOncoinvent ASA
kr 72.20+7.12%50
ZLNA.XOSLZelluna ASA
€1.33-5.67%20
VISTN.XOSLVistin Pharma ASA
€1.76+0.57%81
PHO.XOSLPhotocure ASA
kr 40.85-2.85%88
OMDA.XOSLOmda A/S
€4.07-0.25%42

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing NYKD.XOSL

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.